Physician profile
Jon B Olson
NPI 1487703922
$1,978.60
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,318 · 2020: $661.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $183.04 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $179.57 | 2019-2020 | |
| Zyla Life Sciences, INC. | $163.99 | 2020 | |
| Sentynl Therapeutics, INC. | $139.34 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $139.02 | 2019-2020 | |
| Horizon Therapeutics Plc | $136.63 | 2019 | |
| Pfizer INC. | $127.98 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $122.61 | 2019 | |
| Assertio Therapeutics, INC. | $99.28 | 2019-2020 | |
| Indivior INC. | $94.65 | 2019 | |
| Lilly USA, LLC | $87.35 | 2019-2020 | |
| Amgen INC. | $74.95 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $60.56 | 2019 | |
| Daiichi Sankyo INC. | $57.64 | 2019 | |
| Allergan, INC. | $57.28 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $55.33 | 2019 | |
| Kaleo, INC. | $46.52 | 2019 | |
| Arbor Pharmaceuticals, INC. | $33.82 | 2019-2020 | |
| Stimwave Technologies Incorporated | $24.83 | 2019 | |
| Biodelivery Sciences International, INC. | $23.91 | 2019 | |
| Grt US Holding, INC. | $22.86 | 2019 | |
| Gilead Sciences, INC. | $21.09 | 2019 | |
| Orexo US, INC. | $13.81 | 2020 | |
| Neuronetics, INC. | $12.54 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.